Literature DB >> 6894888

A radioimmunoassay for 1,25-dihydroxycholecalciferol.

R Bouillon, P De Moor, E G Baggiolini, M R Uskokovic.   

Abstract

We describe a radioimmunoassay for 1,25-dihydroxycholecalciferol in human serum. We raised antisera in rabbits to 1,25-dihydroxycholecalciferol-3-hemisuccinate coupled to bovine serum albumin, and obtained sensitive, high-titer antibodies. These antibodies had a high affinity for 1,25-dihydroxycholecalciferol and cross reacted mainly with 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol. Addition of 1 mL of normal rabbit serum per liter reduced this interference to 5 and 4%, respectively. However, these interfering steroids are present in large excess, so extensive purification of 1,25-dihydroxycholecalciferol from serum is necessary. The steroid was extracted with ethyl acetate/cyclohexane, purified on Sephadex LH-20, and then chromatographed on a column of silicic acid. The radioimmunoassay is sensitive to 5 pg/tube (3 ng/L of serum). The between-assay CV was 14%. The mean concentration of 1,25-dihydroxycholecalciferol in the serum of 54 healthy adults was 38 (SD 12) ng/L, with no sex-related difference. The assay was further validated by the finding of low or undetectable concentrations in patients with chronic renal failure and of increased concentrations in the serum of patients with primary hyperparathyroidism. In comparison with previously described methods, the major advantage of the present assay is the use of stable gamma-globulins, which are available in large amounts, as binding protein.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6894888

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  19 in total

1.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

2.  Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.

Authors:  Pieter Evenepoel; Björn Meijers; Liesbeth Viaene; Bert Bammens; Kathleen Claes; Dirk Kuypers; Dirk Vanderschueren; Yves Vanrenterghem
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

3.  Influence of indomethacin on extracellular calcium homeostasis.

Authors:  J W Bijlsma; A J Rabelink
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

4.  Autosomal dominant hypophosphataemia with elevated serum 1,25 dihydroxyvitamin D and hypercalciuria.

Authors:  W C Proesmans; G Fabry; G J Marchal; P L Gillis; R Bouillon
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

5.  Simultaneous measurement of 1.25-dihydroxy-vitamin D, 24.25-dihydroxy-vitamin D and 25-hydroxy-vitamin D from a single two milliliters serum specimen. Preliminary clinical application.

Authors:  D Tartarotti; S Adami; G Galvanini; R Dorizzi; G Piemonte; V Lo Cascio
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

6.  A competitive protein binding assay for 1, 25-dihydroxy vitamin D in blood.

Authors:  M W France; B Lalor
Journal:  Ir J Med Sci       Date:  1981-10       Impact factor: 1.568

7.  Presence of calbindin-D 28K in endocrine pancreatic tumoral cells of the RINm5F line.

Authors:  R Pochet; F Blachier; D E Lawson; W J Malaisse
Journal:  Int J Pancreatol       Date:  1989-10

8.  Effects of weight loss on serum 1,25-(OH)2-vitamin D concentrations in adults: a preliminary report.

Authors:  J Lemann; R W Gray; W J Maierhofer; N D Adams
Journal:  Calcif Tissue Int       Date:  1984-03       Impact factor: 4.333

9.  Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination.

Authors:  T D Shultz; J Fox; H Heath; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

10.  Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.

Authors:  Pieter Evenepoel; Bjorn K I Meijers; Hylke de Jonge; Maarten Naesens; Bert Bammens; Kathleen Claes; Dirk Kuypers; Yves Vanrenterghem
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.